TransMedics Reports Third Quarter 2025 Financial Results
Provided By PR Newswire
Last update: Oct 29, 2025
ANDOVER, Mass., Oct. 29, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended September 30, 2025.
Read more at prnewswire.com
